Healthcare Commercial Due Diligence expert, BiopharmaVantage advises on investment in a novel transdermal drug delivery business

Benchmarking refers to the comparison of the metrics, processes and practices of a particular business to the others in the industry.

Valuation often happens to be the most widely discussed topic in several conferences and forms many research theses. Currently, DCF and comparables based methods are mostly employed valuation methods.

The insights gathered from competitive intelligence (CI) engagements are intelligence not data, thus CI based insights are not amenable to most quantitative methods.

BiopharmaVantage, the specialist Healthcare and Life Sciences Commercial Due Diligence firm, advises on the Investment in an Immunotherapy Business

Biosimilars Competitive Intelligence in the Pharmaceutical and Biotechnology Industry

Due diligence is the process by which buyers conduct investigation and evaluation of potential acquisitions and investments.